OrphAI Therapeutics
Developer of a precision therapeutics technology designed to treat cancer and rare diseases. The company's technology accelerates drug development by deploying technologies including next-gen sequenci...
Valuation
$300M
Market implied
Share Price
N/A
Total Raised
$154.5M
Last Round
N/A